Form 4: Health Catalyst General Counsel Sells Shares

Health Catalyst General Counsel Benjamin Landry sold 27,425 shares of common stock for $2.6373 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Benjamin Landry, General Counsel of Health Catalyst, Inc. (HCAT), reported a sale of common stock.
• The transaction involved the disposition of 27,425 shares of common stock.
• The shares were sold at a price of $2.6373 per share.
• This sale was executed on December 5, 2025.
• The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2025.
• Following this transaction, Benjamin Landry beneficially owns 100,000 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The filing reports a pre-scheduled insider sale under a Rule 10b5-1 plan, which is a routine disclosure and generally considered neutral in terms of immediate company sentiment, as it's not indicative of new positive or negative information.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, though the pre-arranged nature mitigates strong negative interpretations.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Sale of 27,425 shares of common stock by Benjamin Landry, General Counsel, to the open market.

Stakeholder Impact

• Shareholders: May interpret the insider sale differently; those holding shares might see it as a slight negative, while those looking to buy might see it as a liquidity event. The 10b5-1 plan mitigates strong negative interpretations.

Key Dates

Recommendation

The filing details a pre-scheduled insider sale by the General Counsel under a Rule 10b5-1 plan. Such transactions are typically for personal financial planning and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation. Investors should continue to hold based on broader company performance and market conditions.

Keywords

Health Catalyst, HCAT, Insider Trading, Form 4, Stock Sale, Benjamin Landry, General Counsel, 10b5-1 Plan, Equity Transaction